Table 2.
Hematologic response
Response | Imatinib resistant |
Imatinib intolerant |
Total |
|||
---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | |
Cumulative response | ||||||
Evaluable patients | 199 | 88 | 287 | |||
Complete response | 172 | 86 | 75 | 85 | 247 | 86 |
Cumulative response among patients with no baseline complete hematologic response | ||||||
Evaluable patients | 100 | 41 | 141 | |||
Complete response | 76 | 76 | 34 | 83 | 110 | 78 |
Reason for exclusion from analysis | ||||||
No baseline assessment | 1 | 0 | 1 |